Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy
NCT06459193
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Peripheral Neuropathy Due to Chemotherapy
Interventions
DRUG:
Trimetazidine
DRUG:
Placebo
Sponsor
Minia University